Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Knowing the right time to start planning for retirement is essential. Discover the best age to begin securing your financial future.
26,342 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
XRP hovers near $1.15 as traders monitor a crucial technical line. If bulls push above the zone, xrp’s price could ex...
A major software conglomerate trading at a low forward multiple reports a record quarter, driving renewed investor in...
Credit models are evolving as BNPL usage, rent payment history, and trended data tighten the grip on underwriting. Th...
Tesla sits at a fair-value crossroads in 2026, with capex and AI initiatives guiding a modest upside. Here’s how inve...
ADA faces heavy pressure as the market cools, but Cardano’s on-chain activity and social engagement suggest a resilie...
Adobe data shows Prime Day online spending near $26.4 billion, beating forecasts by a slim margin. The four-day event...
Google’s looming compute constraint and a $462 billion backlog set the stage for a broader AI access debate. Investor...
Microsoft shares have fallen sharply this year, yet bulls argue that cloud growth and AI initiatives underpin a resil...
Accenture warns AI’s carbon footprint could rise 11-fold by 2030 as data centers multiply worldwide. The piece examin...
Analysts on Wall Street continue lifting price targets for AMD as AI-enabled datacenters drive revenue growth and exp...
A Goldman Sachs strategist argues Europe is quietly keeping up with the S&P 500 as AI infrastructure demand broadens ...